Opendata, web and dolomites

H2020 projects about "oncogene"

The page lists 26 projects related to the topic "oncogene".

# achronym  title  year 
1 SUMOblock Blocking SUMO conjugation as drug discovery strategy. 2015
2 DDRNA DDRNA-based cancer therapy targeted telomeres 2015
3 DENOVOSTEM DE NOVO GENERATION OF SOMATIC STEM CELLS: REGULATION AND MECHANISMS OF CELL PLASTICITY 2015
4 ALKATRAS ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer 2015
5 SLACC Supplying lung adenocarcinoma cell lines to the cancer research community. 2015
6 PEPTO1 Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy 2016
7 EVI1inCancer Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers 2016
8 MPSC Membrane Potential and Stem Cell Potency in Normal and Malignant Tissues 2016
9 GBM-CPP Developing an anti-Myc cell-penetrating peptide for cancer treatment 2016
10 TKI resistance Resistance mechanisms to tyrosine kinase inhibitors in solid tumors 2016
11 CancerFluxome Cancer Cellular Metabolism across Space and Time 2017
12 RepliStressTiming Impact of replicative stress on DNA replication timing control 2017
13 DSMT16 Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer 2018
14 ONCOGENEVOL The evolutionary history of oncogenic and non-oncogenic papillomaviruses 2017
15 iAML-lncTARGET Targeting the transcriptional landscape in infant AML 2017
16 onCOMBINE Towards evidence-based combinations of approved and novel cancer drugs 2017
17 INSITUMUT Direct detection of cancer-causing mutations in tumour specimens 2018
18 MechDeath Study of the mechanical cues driving cell competition and its role in pretumoral cell expansion 2019
19 TALVIN Inhibiting mechanotransduction for the treatment of pancreatic cancer 2018
20 REPLISTRESS DNA Replication: From Physiology to Replication Stress in Human Cancer 2018
21 CAN-IT-BARRIERS Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors 2020
22 EPICAN Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer 2020
23 Genetic Vaccine Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology 2019
24 CSI AurkA-MYC Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds 2019
25 NUCDDR Nucleolar Responses to DNA Damage: rDNA, an emerging hub of genome instability 2020
26 RASATaC Regulating RAS Activity to Target RAS-Driven Cancers 2020